Health
The Oxford vaccine dilemma – wait for a better jab, or let more people have protection? – Telegraph.co.uk
Regulator seems ready to approve a vaccine with lower efficacy rates. Will it be right giving some people lower chances of being protected?
Drug companies Sanofi and GSK also announced a delay in their Covid-19 vaccine programme on Friday, after trials showed an ‘insufficient response’ in the over-50s.
Some researchers believe the Oxford jab may actually perform better than the 62 per cent efficacy rate suggests. Nobody in the vaccine arm became seriously ill or needed hospital treatment.
Mark Woolhouse, Professor of Infectious Disease Epidemiology at the University of Edinburgh, said: I dont think we should get too hung up on the…
-
Noosa News24 hours agoDeath of German shepherd Arnie prompts Brisbane community action to protect pets caught up in crime
-
General17 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News17 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General19 hours agoPerth man charged after investigation into organised crime and tobacco store attacks